Skip to main content

Public contracts of Corse · 2024

Vaccin contre les infections a méningocoque b

€58k
framework agreement: a maximum envelope for orders over 3.5 years, not spending — what was paid on it is not published
Signed on 5 November 2024 · running until about April 2028 · 3.5 yrs
Ongoing6 Apr 2028

That is at most ~€17k a year on average: a maximum too.

Company selected

Laboratoire GlaxosmithklineCommerce de gros (commerce interentreprises) de produits pharmaceutiques · registered office Rueil-Malmaison (92500) · headcount 1,000 to 1,999 employees · SIREN 642041362

The competition

2 bids received

Median for this procedure in 2024: 3 bids, across 48385 comparable contracts. Simplified procedure · awarded to 1 company

Open data gives the contract holder and the number of bids. The identity of unsuccessful bidders is not published.

Number 329 by amount of the 441 contracts Corse published for 2024.

Other contracts of Laboratoire Glaxosmithkline in Corse

Vaccin hexavalant diphtérie tétanos Polio coqueluche HIB hépatite b2024 · maximum over 4 years92€kVaccins et sérums dans le cadre de la politique vaccinale de la…2024 · maximum over 4 years30€kVaccins et sérums dans le cadre de la politique vaccinale de la…2024 · maximum over 12 months14€k
Contract details (procedure, price, amendments, lots)

Procedure : Adapted procedure: the lighter procedure allowed under the EU thresholds

Framework agreement : yes: orders follow, the amount is a ceiling

Price : Unitaire

Published amendments : 2

Contracts above €40,000 excluding VAT, as declared when they are awarded (DECP): contract amounts, not payments. Smaller contracts are not published; obviously wrong amounts are set aside.